Literature DB >> 10102212

Diseases and problems secondary to massive obesity.

M F Herrara1, R R Lozano-Salazar, J González-Barranco, J A Rull.   

Abstract

Morbid obesity is a health hazard. It carries several health risks and decreases life expectancy. Individuals with morbid obesity may develop one or more complications. These are mainly cardiovascular, metabolic, respiratory, gastrointestinal, renal, genitourinary and gynaecological. Patients with morbid obesity also have a high surgical risk. This review analyses the most common complications of morbidly obese patients and their changes after surgically induced weight loss.

Entities:  

Mesh：

Year:  1999        PMID： 10102212     DOI： 10.1097/00042737-199902000-00002

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN： 0954-691X            Impact factor:   2.566


  5 in total

Review 1.  Medical management of patients after bariatric surgery: Principles and guidelines.

Authors:  Abd Elrazek Mohammad Ali Abd Elrazek; Abduh Elsayed Mohamed Elbanna; Shymaa E Bilasy
Journal:  World J Gastrointest Surg       Date:  2014-11-27

2.  RIRS is equally efficient in patients with different BMI scores.

Authors:  Erdal Alkan; Emre Arpali; A Oguz Ozkanli; Murat M Basar; Oguz Acar; M Derya Balbay
Journal:  Urolithiasis       Date:  2015-01-09       Impact factor: 3.436

3.  Roux-en-Y gastric bypass reverses renal glomerular but not tubular abnormalities in excessively obese diabetics.

Authors:  Jabbar Saliba; Nader R Kasim; Robyn A Tamboli; James M Isbell; Pam Marks; Irene D Feurer; Alp Ikizler; Naji N Abumrad
Journal:  Surgery       Date:  2009-12-11       Impact factor: 3.982

4.  Bronchospasm in obese patients undergoing elective laparoscopic surgery under general anesthesia.

Authors:  Vassilios Tassoudis; Hronis Ieropoulos; Menelaos Karanikolas; George Vretzakis; Aik Bouzia; Elias Mantoudis; Argyro Petsiti
Journal:  Springerplus       Date:  2016-04-12

5.  Early results of recently introduced laparoscopic adjustable gastric banding procedure for morbid obesity in Croatia.

Authors:  T Novinscak; B D Franjic; E Glavan; M Bekavac-Beslin
Journal:  JSLS       Date:  2006 Oct-Dec       Impact factor: 2.172
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.